Cargando…
Prevention of Anthracycline-Induced Cardiotoxicity: The Good and Bad of Current and Alternative Therapies
Doxorubicin (Dox)-induced cardiotoxicity (DIC) remains a serious health burden, especially in developing countries. Unfortunately, the high cost of current preventative strategies has marginalized numerous cancer patients because of socio-economic factors. In addition, the efficacy of these strategi...
Autores principales: | Sangweni, Nonhlakanipho F., van Vuuren, Derick, Mabasa, Lawrence, Gabuza, Kwazi, Huisamen, Barbara, Naidoo, Sharnay, Barry, Reenen, Johnson, Rabia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257015/ https://www.ncbi.nlm.nih.gov/pubmed/35811736 http://dx.doi.org/10.3389/fcvm.2022.907266 |
Ejemplares similares
-
Molecular insights into the pathophysiology of doxorubicin-induced cardiotoxicity: a graphical representation
por: Sangweni, Nonhlakanipho F., et al.
Publicado: (2022) -
Doxorubicin-Induced Cardiomyopathy: A Preliminary Study on the Cardioprotective Benefits of 7-Hydroxyflavanone
por: Sangweni, Nonhlakanipho F., et al.
Publicado: (2023) -
The Prophylactic Effect of Pinocembrin Against Doxorubicin-Induced Cardiotoxicity in an In Vitro H9c2 Cell Model
por: Sangweni, Nonhlakanipho F., et al.
Publicado: (2020) -
Sclerocarya birrea (Marula) Extract Inhibits Hepatic Steatosis in db/db Mice
por: Mabasa, Lawrence, et al.
Publicado: (2022) -
Cardiotoxicity of Anthracyclines
por: Cardinale, Daniela, et al.
Publicado: (2020)